Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a Telehealth program can help speed up treatment for patients experiencing a heart attack known as STEMI (ST-Elevation Myocardial Infarction). When someone calls 9-1-1 in Wilkes County with symptoms that suggest they might be having a STEMI, local paramedics will use this program to get support and advice in real-time. The goal is to find out if this approach helps patients receive quicker care, which is crucial for improving their chances of recovery.
Anyone who calls 9-1-1 with suspected STEMI symptoms in the area may be eligible to be part of the study. There are no specific exclusions since this study aims to gather data for quality improvement. Participants can expect that their care will be closely monitored to help understand how effective the Telehealth program is in emergency situations. Importantly, this trial is not yet recruiting participants, but it will eventually provide valuable insights into heart attack treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients calling 9-1-1 in Wilkes County with possible STEMI as determined by the on scene paramedics will be included in the data.
- Exclusion Criteria:
- • As this is a Quality Surveillance study, subjects will not be excluded.
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Jason Stopyra, MD, MS
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported